hydrocortisone sodium succinate · Pharmacia And Upjohn · NDA 009866
Solu-Cortef
Earliest generic entry, as listed · earliest of 4 marketed strengths
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- 25 Oct 2026Generic approved · 009866-0017 May 2026
- 25 Oct 2026Generic approved · 009866-0015 Feb 2026
Products covered · 4
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 009866 · 001 · RLD | injectable, injection | EQ 100MG BASE/VIAL | open |
| 009866 · 002 · RLD | injectable, injection | EQ 250MG BASE/VIAL | open |
| 009866 · 003 · RLD | injectable, injection | EQ 500MG BASE/VIAL | open |
| 009866 · 004 · RLD | injectable, injection | EQ 1GM BASE/VIAL | open |